← Back to Search

Other

Diagnostic Procedures for Asthma

Phase 1
Recruiting
Led By Benjamin D Medoff, MD, PhD
Research Sponsored by Benjamin Medoff
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age between 18 and 50 years
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1,6, or 24 hours
Awards & highlights

Study Summary

This trial is looking for airway inflammation factors and whether they are linked to atopy and asthma.

Who is the study for?
This trial is for people aged 18-50 who are generally healthy but have allergies to cat dander or dust mites, confirmed by a positive allergy test. They should not smoke and must have normal lung function. Pregnant women, those on certain medications, with recent respiratory infections or other lung diseases, or a history of severe asthma attacks are excluded.Check my eligibility
What is being tested?
The study aims to understand the biological factors causing airway inflammation in asthma patients through procedures like bronchoscopy and broncheoalveolar lavage after exposing participants' lungs to allergens they're sensitive to.See study design
What are the potential side effects?
Potential side effects may include discomfort from the bronchoscopy procedure such as coughing, wheezing, shortness of breath due to the allergen challenge, sore throat, bleeding or infection from where the scope is inserted.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 50 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1,6, or 24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1,6, or 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
airway inflammation

Trial Design

1Treatment groups
Experimental Treatment
Group I: allergic asthmatic, allergic nonasthmatic, healthyExperimental Treatment1 Intervention
Adults who are allergic asthmatics, allergic nonasthmatics, or healthy controls will receive segmental allergen challenge to the lung

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

U.S. Army Medical Research and Development CommandFED
285 Previous Clinical Trials
244,846 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,698 Previous Clinical Trials
7,492,186 Total Patients Enrolled
58 Trials studying Asthma
7,994 Patients Enrolled for Asthma
Benjamin MedoffLead Sponsor

Media Library

Broncheoalveolar Lavage (Other) Clinical Trial Eligibility Overview. Trial Name: NCT00595491 — Phase 1
Asthma Research Study Groups: allergic asthmatic, allergic nonasthmatic, healthy
Asthma Clinical Trial 2023: Broncheoalveolar Lavage Highlights & Side Effects. Trial Name: NCT00595491 — Phase 1
Broncheoalveolar Lavage (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00595491 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent have Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage been scrutinized in other scientific research?

"Presently, there is one active trial for Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage with zero studies in Phase 3. This medical investigation can be accessed at one location located within the city of Boston, Massachusetts."

Answered by AI

Does the protocol for this experiment extend to individuals over 55 years of age?

"To qualify for this research, individuals must be between 18 and 50 years of age. 113 studies are available to those younger than 18 while people over 65 can access 198 trials that cater to their needs."

Answered by AI

How many individuals can participate in this clinical experiment?

"Absolutely. Clinicaltrials.gov reveals that this medical trial is actively recruiting 313 eligible patients, with the initial posting dating back to January 1st 2008 and the last update being on April 4th 2022 from one single location."

Answered by AI

Who is eligible to apply for participation in this research project?

"This clinical trial is recruiting 313 asthma patients ranging from 18 to 50 years old. Eligible participants must possess a FEV1 of no less than 75% the predicted value, demonstrate skin reactivity for cat or dust mite allergen through positive test results, have abstained from smoking for at least 5 years (defined as under 5 pack-years lifetime), be capable of providing informed consent and willing to partake in an interview with the principal investigator."

Answered by AI

Has the Federal Drug Administration (FDA) sanctioned Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage?

"A score of 1 was given to Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage due to the limited evidence in support of its safety efficacy profile."

Answered by AI

Is this experiment still in the process of recruiting participants?

"As indicated on clinicaltrials.gov, this trial is open for patient enrollment and has been since January 1st of 2008. The record was last updated on April 4th 2022."

Answered by AI
~0 spots leftby Apr 2024